CIGNA GROUP FILES (8-K) Disclosing Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure.


2023 Outlook Affirmation

The Cigna Group (the "Company" or "our") officials expect to participate in
meetings with investors and analysts over the next several weeks. During these
meetings, The Cigna Group officials expect to reaffirm projected full year 2023
consolidated adjusted income from operations on a per share basis of at least
$24.60 per share.

The Cigna Group previously discussed its full year 2023 outlook in its press
release and investor presentation dated February 3, 2023, and during the related
investor conference call. The press release, presentation and the conference
call transcript are available in the Investor Relations section of The Cigna
Group's website located at www.thecignagroup.com. Forward-looking statements in
these documents and the related call speak only as of the date they were made.

Adjusted income (loss) from operations is a principal financial measure of
profitability used by The Cigna Group's management because it presents the
underlying results of operations of the Company's businesses and permits
analysis of trends in underlying revenue, expenses and shareholders' net income.
Adjusted income from operations is defined as shareholders' net income (or
income before taxes less pre-tax income (loss) attributable to noncontrolling
interests for the segment metric) excluding net realized investment results,
amortization of acquired intangible assets and special items. The Cigna Group's
share of certain realized investment results of its joint ventures reported in
the Cigna Healthcare segment using the equity method of accounting are also
excluded. Special items are matters that management believes are not
representative of the underlying results of operations due to their nature or
size. Adjusted income (loss) from operations is measured on an after-tax basis
for consolidated results and on a pre-tax basis for segment results.
Consolidated adjusted income (loss) from operations is not determined in
accordance with GAAP and should not be viewed as a substitute for the most
directly comparable GAAP measure, shareholders' net income.

Management is not able to provide a reconciliation of adjusted income from
operations to shareholders' net income (including on a per share basis) on a
forward-looking basis because we are unable to predict, without unreasonable
effort, certain components thereof including (i) future net realized investment
results (from equity method investments with respect to adjusted revenues) and
(ii) future special items. These items are inherently uncertain and depend on
various factors, many of which are beyond our control. As such, any associated
estimate and its impact on shareholders' net income could vary materially.

This information shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act whether made before or after the date of this
report, except as shall be expressly set forth by specific reference in such a
filing.

-2-

 CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE PRIVATE
                    SECURITIES LITIGATION REFORM ACT OF 1995

This Current Report on Form 8-K (the "Report"), and oral statements made with
respect to information contained in this Report, may contain forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of
1995. Forward-looking statements are based on The Cigna Group's current
expectations and projections about future trends, events and uncertainties.
These statements are not historical facts. Forward-looking statements may
include, among others, statements concerning our projected adjusted income from
operations for 2023 on a consolidated, per share basis; projected weighted
average shares outstanding; future financial or operating performance, including
our ability to improve the health and vitality of those we serve; future growth,
business strategy and strategic or operational initiatives; economic, regulatory
or competitive environments, particularly with respect to the pace and extent of
change in these areas and the impact of developing inflationary and interest
rate pressures; financing or capital deployment plans and amounts available for
future deployment; our prospects for growth in the coming years; strategic
transactions; The Cigna Group's future beliefs, expectations, plans, intentions,
liquidity, cash flows, financial condition or performance. You may identify
forward-looking statements by the use of words such as "believe," "expect,"
"project", "plan," "intend," "anticipate," "estimate," "predict," "potential,"
"may," "should," "will" or other words or expressions of similar meaning,
although not all forward-looking statements contain such terms.

Forward-looking statements are subject to risks and uncertainties, both known
and unknown, that could cause actual results to differ materially from those
expressed or implied in forward-looking statements. Such risks and uncertainties
include, but are not limited to: our ability to achieve our strategic and
operational initiatives; our ability to adapt to changes in an evolving and
rapidly changing industry; our ability to compete effectively, differentiate our
products and services from those of our competitors and maintain or increase
market share; price competition, inflation and other pressures that could
compress our margins or result in premiums that are insufficient to cover the
cost of services delivered to our customers; the potential for actual claims to
exceed our estimates related to expected medical claims; our ability to develop
and maintain satisfactory relationships with physicians, hospitals, other health
service providers and with producers and consultants; our ability to maintain
relationships with one or more key pharmaceutical manufacturers or if payments
made or discounts provided decline; changes in the pharmacy provider marketplace
or pharmacy networks; changes in drug pricing or industry pricing benchmarks;
our ability to invest in and properly maintain our information technology and
other business systems; our ability to prevent or contain effects of a potential
cyberattack or other privacy or data security incident; the scale, scope and
duration of the COVID-19 pandemic and its potential impact on our business,
operating results, cash flows or financial condition; political, legal,
operational, regulatory, economic and other risks that could affect our
multinational operations, including currency exchange rates; risks related to
strategic transactions and realization of the expected benefits of such
transactions, as well as integration or separation difficulties or
underperformance relative to expectations; dependence on success of
relationships with third parties; risk of significant disruption within our
operations or among key suppliers or third parties; potential liability in
connection with managing medical practices and operating pharmacies, onsite
clinics and other types of medical facilities; the substantial level of
government regulation over our business and the potential effects of new laws or
regulations or changes in existing laws or regulations; uncertainties
surrounding participation in government-sponsored programs such as Medicare; the
outcome of litigation, regulatory audits and investigations; compliance with
applicable privacy, security and data laws, regulations and standards; potential
failure of our prevention, detection and control systems; unfavorable economic
and market conditions including the risk of a recession or other economic
downturn and resulting impact on employment metrics, stock market or changes in
interest rates and risks related to a downgrade in financial strength ratings of
our insurance subsidiaries; the impact of our significant indebtedness and the
potential for further indebtedness in the future; unfavorable industry, economic
or political conditions; credit risk related to our reinsurers; as well as more
specific risks and uncertainties discussed in our most recent report on Form
10-K and subsequent reports on Forms 10-Q and 8-K available through the Investor
Relations section of www.thecignagroup.com. You should not place undue reliance
on forward-looking statements, which speak only as of the date they are made,
are not guarantees of future performance or results, and are subject to risks,
uncertainties and assumptions that are difficult to predict or quantify. The
Cigna Group undertakes no obligation to update or revise any forward-looking
statement, whether as a result of new information, future events or otherwise,
except as may be required by law.